{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:17:13Z","timestamp":1788448633785,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding","doi-asserted-by":"crossref","award":["ZYLX201702"],"award-info":[{"award-number":["ZYLX201702"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals' Ascent Plan","doi-asserted-by":"crossref","award":["DFL20180101"],"award-info":[{"award-number":["DFL20180101"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"crossref","award":["7181003"],"award-info":[{"award-number":["7181003"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.clim.2019.03.006","type":"journal-article","created":{"date-parts":[[2019,3,23]],"date-time":"2019-03-23T11:55:51Z","timestamp":1553342151000},"page":"18-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["The inhibitory receptors on NK cells and CTLs are upregulated in adult and adolescent patients with secondary hemophagocytic lymphohistiocytosis"],"prefix":"10.1016","volume":"202","author":[{"given":"Zhuo","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yini","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingshi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2019.03.006_bb0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes--an update","volume":"28","author":"Janka","year":"2014","journal-title":"Blood Rev."},{"key":"10.1016\/j.clim.2019.03.006_bb0010","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.clim.2019.03.006_bb0015","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.03.006_bb0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/bjh.14147","article-title":"Advances in the pathogenesis of primary and secondary haemophagocytic lymphohistiocytosis: differences and similarities","volume":"174","author":"Brisse","year":"2016","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2019.03.006_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2014.05.005","article-title":"Cytokine balance and cytokine-driven natural killer cell dysfunction in systemic juvenile idiopathic arthritis","volume":"26","author":"Avau","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2019.03.006_bb0030","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.20140964","article-title":"Failed CTL\/NK cell killing and cytokine hypersecretion are directly linked through prolonged synapse time","volume":"212","author":"Jenkins","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2019.03.006_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","article-title":"NK cell recognition","volume":"23","author":"Lanier","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2005.07.004","article-title":"Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis","volume":"100","author":"Moretta","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2019.03.006_bb0045","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.celrep.2017.08.071","article-title":"Culturing CTLs under hypoxic conditions enhances their cytolysis and improves their anti-tumor function","volume":"20","author":"Gropper","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2019.03.006_bb0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood-2014-09-602946","article-title":"A novel immunoregulatory role for NK-cell cytotoxicity in protection from HLH-like immunopathology in mice","volume":"125","author":"Sepulveda","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.03.006_bb0055","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2010.04302.x","article-title":"Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management","volume":"163","author":"Gholam","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/cmi.2016.23","article-title":"Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway","volume":"14","author":"Wang","year":"2017","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0070","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0075","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/s00262-004-0517-9","article-title":"The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape","volume":"53","author":"Algarra","year":"2004","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2019.03.006_bb0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.clim.2019.03.006_bb0085","first-page":"1034","article-title":"NK cell surface receptors and their research progress - review","volume":"20","author":"Liu","year":"2012","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.clim.2019.03.006_bb0090","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00005-011-0137-y","article-title":"Clinical significance of the HLA-E and CD94\/NKG2 interaction","volume":"59","author":"Iwaszko","year":"2011","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.clim.2019.03.006_bb0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.287.5455.1031","article-title":"Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40","volume":"287","author":"Tomasec","year":"2000","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.clim.2019.03.006_bb0100","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.4049\/jimmunol.170.7.3572","article-title":"Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells","volume":"170","author":"Rabinovich","year":"2003","journal-title":"J. Immunol. (Baltimore, MD : 1950)"},{"key":"10.1016\/j.clim.2019.03.006_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2019.03.006_bb0110","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.4049\/jimmunol.1004122","article-title":"Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses","volume":"186","author":"Soderquest","year":"2011","journal-title":"J. Immunol. (Baltimore, MD : 1950)"},{"key":"10.1016\/j.clim.2019.03.006_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clim.2019.03.006_bb0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0125","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","article-title":"Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway","volume":"26","author":"Lu","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2019.03.006_bb0130","doi-asserted-by":"crossref","first-page":"14584","DOI":"10.1073\/pnas.1112188108","article-title":"Mobilization of natural killer cells inhibits development of collagen-induced arthritis","volume":"108","author":"Leavenworth","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2019.03.006_bb0135","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0140","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/ni.1679","article-title":"Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection","volume":"10","author":"Blackburn","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2019.03.006_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2016.02.007","article-title":"Recent advances in viral evasion of the MHC class I processing pathway","volume":"40","author":"Schuren","year":"2016","journal-title":"Curr. Opin. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661618305321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:58:23Z","timestamp":1761494303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661618305321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":29,"alternative-id":["S1521661618305321"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2019.03.006","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The inhibitory receptors on NK cells and CTLs are upregulated in adult and adolescent patients with secondary hemophagocytic lymphohistiocytosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2019.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}